JP2020514689A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020514689A5 JP2020514689A5 JP2019531802A JP2019531802A JP2020514689A5 JP 2020514689 A5 JP2020514689 A5 JP 2020514689A5 JP 2019531802 A JP2019531802 A JP 2019531802A JP 2019531802 A JP2019531802 A JP 2019531802A JP 2020514689 A5 JP2020514689 A5 JP 2020514689A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- biological sample
- timp1
- lrg1
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000427 antigen Substances 0.000 claims 39
- 102000036639 antigens Human genes 0.000 claims 39
- 108091007433 antigens Proteins 0.000 claims 39
- 238000000034 method Methods 0.000 claims 20
- RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 claims 16
- 239000012472 biological sample Substances 0.000 claims 16
- 201000008129 pancreatic ductal adenocarcinoma Diseases 0.000 claims 16
- 101000783723 Homo sapiens Leucine-rich alpha-2-glycoprotein Proteins 0.000 claims 14
- 101000669513 Homo sapiens Metalloproteinase inhibitor 1 Proteins 0.000 claims 14
- 102100035987 Leucine-rich alpha-2-glycoprotein Human genes 0.000 claims 14
- 102100039364 Metalloproteinase inhibitor 1 Human genes 0.000 claims 14
- 238000001514 detection method Methods 0.000 claims 11
- NQNXERHVLXYXRO-UHFFFAOYSA-N Diacetylspermine Chemical compound Cl.Cl.CC(=O)NCCCNCCCCNCCCNC(C)=O NQNXERHVLXYXRO-UHFFFAOYSA-N 0.000 claims 8
- 239000000090 biomarker Substances 0.000 claims 7
- FONIWJIDLJEJTL-UHFFFAOYSA-N N(8)-acetylspermidine Chemical compound CC(=O)NCCCCNCCCN FONIWJIDLJEJTL-UHFFFAOYSA-N 0.000 claims 5
- 150000002475 indoles Chemical class 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 239000012634 fragment Substances 0.000 claims 3
- 238000003018 immunoassay Methods 0.000 claims 3
- 239000003153 chemical reaction reagent Substances 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 208000016222 Pancreatic disease Diseases 0.000 claims 1
- 229940054051 antipsychotic indole derivative Drugs 0.000 claims 1
- 238000004949 mass spectrometry Methods 0.000 claims 1
- 238000005259 measurement Methods 0.000 claims 1
- 238000000691 measurement method Methods 0.000 claims 1
- 239000002207 metabolite Substances 0.000 claims 1
- 229920000371 poly(diallyldimethylammonium chloride) polymer Polymers 0.000 claims 1
- 239000012474 protein marker Substances 0.000 claims 1
- 238000007619 statistical method Methods 0.000 claims 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023011264A JP2023055806A (ja) | 2016-12-15 | 2023-01-27 | 膵管腺癌の検出および処置のための方法 |
| JP2025080930A JP2025118850A (ja) | 2016-12-15 | 2025-05-14 | 膵管腺癌の検出および処置のための方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662435020P | 2016-12-15 | 2016-12-15 | |
| US201662435024P | 2016-12-15 | 2016-12-15 | |
| US62/435,024 | 2016-12-15 | ||
| US62/435,020 | 2016-12-15 | ||
| PCT/US2017/066851 WO2018112428A1 (en) | 2016-12-15 | 2017-12-15 | Methods for the detection and treatment of pancreatic ductal adenocarcinoma |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023011264A Division JP2023055806A (ja) | 2016-12-15 | 2023-01-27 | 膵管腺癌の検出および処置のための方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020514689A JP2020514689A (ja) | 2020-05-21 |
| JP2020514689A5 true JP2020514689A5 (enExample) | 2021-02-04 |
Family
ID=62559366
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019531802A Pending JP2020514689A (ja) | 2016-12-15 | 2017-12-15 | 膵管腺癌の検出および処置のための方法 |
| JP2023011264A Pending JP2023055806A (ja) | 2016-12-15 | 2023-01-27 | 膵管腺癌の検出および処置のための方法 |
| JP2025080930A Pending JP2025118850A (ja) | 2016-12-15 | 2025-05-14 | 膵管腺癌の検出および処置のための方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023011264A Pending JP2023055806A (ja) | 2016-12-15 | 2023-01-27 | 膵管腺癌の検出および処置のための方法 |
| JP2025080930A Pending JP2025118850A (ja) | 2016-12-15 | 2025-05-14 | 膵管腺癌の検出および処置のための方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US20200182876A1 (enExample) |
| EP (1) | EP3555628A4 (enExample) |
| JP (3) | JP2020514689A (enExample) |
| KR (1) | KR102549063B1 (enExample) |
| CN (1) | CN110121647A (enExample) |
| WO (1) | WO2018112428A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3064940B1 (en) * | 2013-10-28 | 2019-07-03 | Salivatech Co., Ltd. | Salivary biomarker for pancreatic cancer |
| CN110646554B (zh) * | 2019-09-12 | 2022-05-13 | 北京博远精准医疗科技有限公司 | 基于代谢组学的胰腺癌诊断标志物及其筛选方法和应用 |
| RU2745793C1 (ru) * | 2020-02-26 | 2021-04-01 | Государственное бюджетное учреждение здравоохранения города Москвы городская клиническая больница имени С.П. Боткина департамента здравоохранения города Москвы (ГБУЗ ГКБ им. С.П. Боткина ДЗМ) | Способ расчета средней продолжительности жизни у пациентов с метастатической аденокарциномой поджелудочной железы |
| CN115125312B (zh) * | 2021-03-26 | 2025-07-18 | 中国科学院上海营养与健康研究所 | 用于Basal型胰腺导管腺癌(PDAC)诊断的标志物组合及其应用 |
| CN113777309A (zh) * | 2021-09-07 | 2021-12-10 | 复旦大学附属肿瘤医院 | 自身抗体在制备胰腺导管腺癌诊断试剂盒中的应用 |
| CN113917008A (zh) * | 2021-09-09 | 2022-01-11 | 广州济士源生物技术有限公司 | 质谱检测尿液中代谢物水平的产品在制备用于早期评估肠道息肉和结直肠癌产品中的应用 |
| CN114487201A (zh) * | 2022-02-09 | 2022-05-13 | 江西省肿瘤医院(江西省第二人民医院、江西省癌症中心) | 鼻咽癌相关尿液标志物组合的检测试剂的应用 |
| AU2023221839A1 (en) * | 2022-02-15 | 2024-08-22 | Kite Pharma, Inc. | Predicting adverse events from immunotherapy. |
| WO2024059549A2 (en) * | 2022-09-12 | 2024-03-21 | Board Of Regents, The University Of Texas System | Methods for the detection and treatment of pancreatic ductal adenocarcinoma |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100092476A1 (en) * | 2006-11-17 | 2010-04-15 | Hanash Samir M | Pancreatic cancer biomarkers |
| US10024857B2 (en) * | 2009-10-01 | 2018-07-17 | Med-Life Discoveries Lp | Serum-based biomarkers of pancreatic cancer and uses thereof for disease detection and diagnosis |
| AU2012343843B2 (en) * | 2011-11-30 | 2018-03-08 | Metanomics Health Gmbh | Device and methods to diagnose pancreatic cancer |
| US20140271621A1 (en) * | 2013-03-14 | 2014-09-18 | Abbott Laboratories | Methods of prognosis and diagnosis of pancreatic cancer |
| EP3064940B1 (en) * | 2013-10-28 | 2019-07-03 | Salivatech Co., Ltd. | Salivary biomarker for pancreatic cancer |
| AU2014368412A1 (en) * | 2013-12-20 | 2016-07-07 | Metanomics Health Gmbh | Means and methods for diagnosing pancreatic cancer in a subject based on a metabolite panel |
| KR20160045547A (ko) * | 2014-10-17 | 2016-04-27 | 에스케이텔레콤 주식회사 | 췌장암 진단용 조성물 및 이를 이용한 췌장암 진단방법 |
-
2017
- 2017-12-15 US US16/469,065 patent/US20200182876A1/en not_active Abandoned
- 2017-12-15 JP JP2019531802A patent/JP2020514689A/ja active Pending
- 2017-12-15 EP EP17881193.1A patent/EP3555628A4/en active Pending
- 2017-12-15 KR KR1020197019752A patent/KR102549063B1/ko active Active
- 2017-12-15 WO PCT/US2017/066851 patent/WO2018112428A1/en not_active Ceased
- 2017-12-15 CN CN201780080968.1A patent/CN110121647A/zh active Pending
-
2022
- 2022-11-10 US US18/054,307 patent/US20230324394A1/en not_active Abandoned
-
2023
- 2023-01-27 JP JP2023011264A patent/JP2023055806A/ja active Pending
-
2025
- 2025-02-27 US US19/065,894 patent/US20250298025A1/en active Pending
- 2025-05-14 JP JP2025080930A patent/JP2025118850A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020514689A5 (enExample) | ||
| Richardson et al. | Role of serological tests in the diagnosis of mold infections | |
| Yi et al. | Alpha-fetoprotein-L3 in hepatocellular carcinoma: a meta-analysis | |
| De Vincentis et al. | Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study | |
| JP2020510816A5 (enExample) | ||
| Brekelmans et al. | Smelling the diagnosis: The electronic nose as diagnostic tool in inflammatory arthritis. A case-reference study | |
| JP2020526747A5 (enExample) | ||
| JPWO2016163539A1 (ja) | 肝疾患の病態を判別する方法 | |
| Kruse et al. | Development of electrochemiluminescence-based singleplex and multiplex assays for the quantification of α-synuclein and other proteins in cerebrospinal fluid | |
| JP2008533471A5 (enExample) | ||
| Kamada et al. | Reevaluation of a lectin antibody ELISA kit for measuring fucosylated haptoglobin in various conditions | |
| WO2006026020A3 (en) | Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin | |
| EP3440465A2 (en) | Methods and systems for metabolite and/or lipid-based detection of colorectal cancer and/or adenomatous polyps | |
| Cristaudo et al. | Combined serum mesothelin and plasma osteopontin measurements in malignant pleural mesothelioma | |
| Wu et al. | Development of a highly sensitive glycan microarray for quantifying AFP-L3 for early prediction of hepatitis B virus–related hepatocellular carcinoma | |
| CN113791221A (zh) | 一种检测急性主动脉夹层的生物标志物及其应用 | |
| PL1776587T3 (pl) | Zastosowanie C3A i jego pochodnych jako biomarkera do leczenia gruczolaka i/lub raka jelita grubego; metody diagnostyczne i testy z ich użyciem | |
| JP7179356B2 (ja) | 代謝物分析を利用したベーチェット病の診断方法 | |
| RU2013158667A (ru) | Способ диагностики болезни гоше | |
| JP7650538B2 (ja) | 血液由来エクソソームから見出した新規アルツハイマー病診断用バイオマーカー及びそれを用いたアルツハイマー病診断方法 | |
| Shi et al. | CK-19 mRNA-positive cells in peripheral blood predict treatment efficacy and survival in small-cell lung cancer patients | |
| Oberpenning et al. | Semi-quantitative immunochromatographic test for prostate specific antigen in whole blood: tossing the coin to predict prostate cancer? | |
| Hasibeder et al. | Evaluation and validation of the detection of soluble triggering receptor expressed on myeloid cells 1 by enzyme-linked immunosorbent assay | |
| Sogawa et al. | Serum fibrinogen alpha C‐chain 5.9 k D a fragment as a biomarker for early detection of hepatic fibrosis related to hepatitis C virus | |
| Kruse et al. | Validation of a commercially available enzyme-linked immunoabsorbent assay for the quantification of human α-Synuclein in cerebrospinal fluid |